Portugal's Parliament has pushed through a last-minute legal patch that will prevent €880M worth of anti-trust fines from expiring due to statute-of-limitations technicalities. The new statute—Law 51/2026—went into force yesterday, applying updated prescription rules to 19 pending competition cases that span banking, energy, telecoms, and retail sectors.
Why This Matters:
• €880M in corporate penalties are now shielded from automatic cancellation, extending the window for final court rulings.
• Multiple cases are already escalated to the European Court of Justice, meaning delays that previously triggered expiry dates will no longer count against the clock.
• Businesses under investigation face prolonged legal uncertainty, while consumer advocates argue the measure protects competitive market integrity.
The Banking Cartel Fiasco That Forced Parliament's Hand
The immediate catalyst for this legislative sprint was the collapse of Portugal's largest-ever competition enforcement action. In February 2025, the Lisbon Court of Appeal threw out €225M in fines against 11 banks accused of exchanging commercially sensitive data between 2002 and 2013. The Competition, Regulation, and Supervision Court had upheld the penalties in September 2024, but the appeal bench ruled that time had run out under the old statute-of-limitations framework.
The two courts clashed over a single procedural wrinkle: whether the years spent waiting for a European Court of Justice ruling should pause the prescription countdown. The trial court said yes; the appeal panel said no—by a split vote of 2-to-1. That divergence wiped out the single largest fine in Portugal Competition Authority history and sent shockwaves through Lisbon's regulatory community.
By July 2026, the Competition Authority's president, Nuno Cunha Rodrigues, had publicly disclosed that 19 contraordenacional proceedings totaling up to €880M were at risk of the same fate. Of those, several had already been referred to Luxembourg for preliminary rulings, creating multi-year procedural pauses that the old prescription regime did not formally recognize.
How the New Law Rewrites the Clock
Law 51/2026 contains a single operative clause: it decrees that Law 17/2022—the statute that transposed EU Directive 2019/1 and overhauled Portugal's competition framework—applies retroactively to all cases that were open on August 18, 2026. In practical terms, this means:
• Referrals to the European Court of Justice now formally suspend prescription timers, aligning Portuguese procedure with EU enforcement norms.
• Older cases filed under the pre-2022 regime will be judged under the more lenient countdown rules introduced four years ago.
• Courts must uniformly apply the trial-level interpretation that favored extended deadlines, closing the door on appeal-court reinterpretation.
The statute is brief—just one article—but its effect is sweeping. It retroactively harmonizes the legal ground beneath two dozen high-stakes proceedings, most of which involve household-name corporations and date back more than a decade.
What This Means for Businesses and Investors
For companies caught in the Competition Authority's crosshairs, the new law eliminates a potential escape hatch. Defense strategies that hinged on running out the clock are now defunct. Firms in sectors under scrutiny—banking, telecoms, energy, and large-scale retail—should brace for protracted litigation timelines, particularly if their cases involve EU-level legal questions.
The 19 active proceedings cover:
• Banking sector collusion (information-sharing and pricing coordination)
• Energy market manipulation (bid-rigging and capacity withholding)
• Telecom bundling practices (tied sales and margin squeezes)
• Retail supply-chain abuses (buyer-power exploitation and vertical restraints)
The aggregate €880M in fines represents roughly 0.3% of Portugal's annual GDP, a scale that underscores the economic weight of these enforcement actions. For multinationals operating in Portugal, the precedent is clear: prescription will no longer function as a de facto statute of repose.
Constitutional Battle Lines and Legislative Debate
The bill's path through Portugal's Assembly of the Republic was contentious. Introduced by the Portuguese Communist Party (PCP) in the wake of the banking-cartel reversal, the measure initially failed in the Committee on Economy and Territorial Cohesion on July 15. The PCP invoked a procedural maneuver to force a full-chamber vote, where it passed on July 17 with support from PS, Chega, Livre, BE, PAN, and JPP. PSD and CDS-PP voted against; IL abstained.
Center-right opposition was fierce. CDS-PP deputy Paulo Núncio denounced the statute as "flagrantly unconstitutional," arguing that retroactive application of limitation rules violates due-process guarantees and undermines legal certainty. The party contends that applying 2022 rules to cases filed under the old regime breaches the constitutional prohibition on retroactive criminal and quasi-criminal law—a doctrine that extends to administrative sanctions.
PSD echoed the critique but offered fewer public details. Both parties frame the measure as a policy decision that raises questions about balancing rule-of-law principles with enforcement continuity. The Competition Authority, by contrast, welcomed the clarity, stating that the change "reinforces legal certainty and predictability in law application"—a view that treats uniform prescription rules as more stable than court-by-court variance.
What Happens to the Banking Cartel Case?
The €225M in fines against the 11 banks were struck down by the Lisbon Court of Appeal in February 2025 based on prescription grounds. This decision ended that particular enforcement action. Law 51/2026 applies only to pending matters going forward; it cannot resurrect cases that have been definitively concluded. The new statute is designed to prevent similar prescription-based dismissals in the 19 ongoing proceedings.
The legislative choice reflects Parliament's response to the enforcement collapse: extending the statute-of-limitations window for future cases while accepting that the banking-cartel penalties cannot be recovered.
Authority's Track Record and Sector Exposure
The Portugal Competition Authority has been one of Europe's more aggressive national enforcers over the past 15 years, launching investigations across nearly every major economic sector. The 19 cases now insulated from prescription include some of the longest-running battles in Portuguese regulatory history, with evidentiary records spanning more than a decade and involving terabytes of internal communications, pricing data, and market analytics.
For energy companies, ongoing cases scrutinize wholesale-market bidding behavior during the Iberian electricity market integration. Telecom firms face allegations of bundling fixed-line, mobile, and content services in ways that foreclose rival entry. Retailers are accused of leveraging buyer power to extract unlawful rebates from suppliers, distorting shelf-space allocation and promotional calendars.
The scale and sectoral breadth of these proceedings mean that nearly every major corporate group operating in Portugal has either direct exposure or supply-chain entanglement with at least one of the 19 files.
Broader Implications for EU Competition Enforcement
Portugal's move mirrors a broader EU trend toward extending enforcement timelines and harmonizing national procedures. Directive 2019/1, which Law 17/2022 transposed, was designed to give member-state competition authorities greater investigative powers and longer enforcement windows, aligning national practice with the European Commission's own procedures.
The prescription controversy exposes a recurring friction in EU law: the tension between procedural autonomy (each member state sets its own deadlines and remedies) and substantive harmonization (everyone enforces the same competition rules). Portugal's retroactive application of the 2022 framework tilts decisively toward harmonization, prioritizing alignment with Brussels over domestic procedural tradition.
For foreign investors and multinational firms, the lesson is straightforward: EU competition enforcement operates on long fuses. Cases can survive judicial delays, appellate proceedings, and referrals to Luxembourg. Prescription is no longer a reliable exit strategy, and defense budgets should assume multi-year litigation horizons.
Next Steps and Unresolved Questions
The Competition Authority has not disclosed which of the 19 cases are closest to final resolution or which carry the largest individual fines. Based on historical patterns, banking and energy files tend to generate the highest penalties, often in the €50M–€100M range per defendant.
Constitutional challenges remain possible. CDS-PP's allegation that the statute violates due-process norms could be tested if a defendant asks the Constitutional Court to review Law 51/2026's compatibility with Article 29 of the Portuguese Constitution, which enshrines legal certainty and the principle of legality in criminal and quasi-criminal matters. That review, if granted, could take years—time during which the law remains in force.
For now, the immediate effect is clear: Portugal's competition enforcers have secured a legislative framework that prevents their major cases from being dismissed on prescription grounds. Whether that framework withstands legal challenge, and whether the underlying fines are upheld or overturned on the merits, remains to be determined by the courts.
